People | June 04, 2026
Alembic appoints Ramesh Juneja as Executive Vice President – Human Health for India business
Juneja brings more than three decades of experience in pharmaceutical sales and marketing
Juneja brings more than three decades of experience in pharmaceutical sales and marketing
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
The approval is expected to support the company’s presence in regulated international markets and further strengthen its position as a reliable pharma manufacturing partner
Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market
Veteran pharmaceutical executive to relocate to Saudi Arabia and spearhead Cipla’s growth strategy across the Middle East region
The initiative opens pathways for female students to pursue healthcare programs across 20+ top universities and colleges in India
Accreditations for Bhayla manufacturing site strengthen the company’s global quality credentials and support expansion of its hormone portfolio into regulated international markets
Acquisition provides direct access to the Dutch healthcare market, enhancing Marksans’ sales, distribution and market-access capabilities across regulated European markets
First immunotherapy combination approved in the US for BCG-naïve high-risk NMIBC demonstrates a 32% reduction in the risk of disease recurrence, progression, or death
Based in the global marketing function, he will be responsible for strengthening the company's visibility among sponsors, partners and industry stakeholders worldwide
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
